At Biopôle since 2011.
Actigenomics has developed a groundbreaking new family of nutritional actives, EFSA and FDA approved. First products target four major public problems: cholesterol control, immune deficiencies, bone metabolism and sleep troubles. There are the most effective non drug products on these markets, with unique mechanism of action rebalancing body natural regulatory mechanisms, without detrimental effect. Already patented or in process.